retatrutide dopamine GIPR signaling reduces release in the brain | Andrew Hardaway posted on the topic Retatrutide Explained: The Triple Agonist

Risks : Fluid retention, potential heart failure

This timeline aligns with clinical observations showing that significant results typically become visible after 6-8 weeks of consistent treatment

It stimulates collagen production, reduces inflammation, and promotes wound healing

For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease

It's not currently licensed in the UK, so it can't be prescribed or purchased here yet